MaRI
Kyoto
About MaRI
MaRI develops SAS technologies to solve daily sleep-blocking factors in a human-friendly way. They provide SAS devices to resolve hypopnea and apnea with low-frequency irradiation technology without burdening patients. Their non-contact SAS device also treats illnesses such as heart failure, arrhythmias, stroke, and diabetes.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $5.7M
- Funding stage: Early Stage Venture
- Last round: Series B (Feb 2024)
- Website: marisleep.co.jp
- Phone: +81-75-315-8997
Industries & Categories
Health Care, Manufacturing, Medical, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/mari-23713 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.